This August, TikaMobile made the cover the Pharma Tech Outlook Enterprise Software 2020 Magazine. Nominated as a top 10 Pharma Enterprise Solutions provider, TikaMobile's feature includes a write up depicting how the company is alleviating Covid-19 pressure for the Life Sciences industry with remote collaboration capabilities.
In the face of the technology revolution, many organizations typically have a tough time adjusting to new ways of thinking. Instead of embracing innovation, it sometimes is easier to rely on old traditional platforms and systems that tend to hinder their ability to be more efficient and organized. Especially in the life sciences industry, there are several functions that could immensely benefit from doing away with legacy systems and antiquated workflow management.
Although technology is disrupting the life sciences industry, it presents many opportunities to pharmaceutical and medical device companies who are willing to step outside of their comfort zones. Especially with the increase in remote work and collaboration, a life science organization that can embody a strong digital strategy, can boost efficiencies and performance across all functional areas, especially for commercial and medical affairs teams.
Performance management can be a tough skill for life sciences organizations to master, however, when the process is crafted strategically and carefully, it easily becomes a competitive advantage.
According to McKinsey, Medical Affairs teams are growing to become the third strategic pillar in life sciences organizations. Having enhanced data capabilities and expertise in collaborating with key stakeholders makes Medical Affairs well-equipped to provide the strategic support needed to seek RWE and optimize product life cycles and, ultimately, patient outcomes.
There is an increased need for sales leadership intelligence within life science organizations. High quality intelligence not only helps senior leaders support and coach their commercial team but also personally helps them become better decision makers, stay agile, and positively impact the bottom line.
Key performance indicators (KPIs) are essential for monitoring the success of your business and deciding whether or not to reevaluate your current strategy. When it comes to the life sciences industry, carefully selecting KPIs for your commercial and medical teams will benefit your organization in the long-run.
